Literature DB >> 11284524

Unusual presentation of primary hyperparathyroidism with osteoporosis, hypercalcemia, and normal parathyroid hormone level.

J B Perez1, A G Pazianos.   

Abstract

We report the case of a woman with osteoporosis, chronic hypercalcemia, and normal levels of parathyroid hormone (PTH). Surgical exploration revealed hyperplasia of the parathyroid glands. Hypercalcemia was corrected immediately by surgery, and this was followed by a dramatic improvement in bone mineral density. This case represents a rarely reported presentation of primary hyperparathyroidism with an atypical laboratory finding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284524

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism.

Authors:  David F Schneider; Jocelyn F Burke; Kristin A Ojomo; Nicholas Clark; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-08-14       Impact factor: 5.344

2.  Treatment of eggshell with casein phosphopeptide reduces the severity of ovariectomy-induced bone loss.

Authors:  Jung-Hoon Kim; Min Seuk Kim; Hong-Geun Oh; Hak-Yong Lee; Jeong-Woo Park; Bong-Gun Lee; Sang-Hoon Park; Dae-In Moon; Eun-Hye Shin; Eun-Kyeong Oh; Munkhsoyol Erkhembaatar; Okjin Kim; Yong-Rae Lee; Han-Jung Chae
Journal:  Lab Anim Res       Date:  2013-06-24

3.  Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.

Authors:  Fabio Medas; Enrico Erdas; Giulia Loi; Francesco Podda; Lucia Barca; Giuseppe Pisano; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

4.  Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.

Authors:  Heather Stuart; Basem Azab; Omar Picado Roque; Janice Pasieka; John I Lew
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

5.  Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.

Authors:  Angela Gurrado; Andrea Marzullo; Germana Lissidini; Agostino Lippolis; Domenico Rubini; Gaetano Lastilla; Mario Testini
Journal:  World J Surg Oncol       Date:  2008-02-21       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.